EF1a-hTERT Lentiviral Particles

The EF1a-hTERT Lentiviral Particles are a sophisticated molecular tool engineered for the stable delivery and constitutive expression of the human telomerase reverse transcriptase (hTERT) gene. These particles leverage the Human elongation factor-1 alpha (EF1a) promoter, a potent regulatory element that ensures high-level transcriptional activity across an expansive variety of mammalian cell lines, including notoriously difficult-to-transduce primary cells and pluripotent stem cells. Unlike other viral promoters that may face epigenetic silencing over time, the EF1a promoter provides reliable, long-term expression of the hTERT protein. This system employs a third-generation lentiviral vector framework, which enhances biosafety by utilizing a split-genome packaging strategy. Upon transduction, the viral RNA is reverse-transcribed and integrated into the host cell’s genome, providing a permanent genetic modification that enables the cell to overcome telomere-dependent replicative senescence.

In terms of research utility, the EF1a-hTERT Lentiviral Particles serve as a cornerstone for the creation of immortalized yet phenotypically normal cell lines. By replenishing telomeric DNA, hTERT allows researchers to bypass the Hayflick limit in primary human cells—such as fibroblasts, endothelial cells, and specialized immune cells—without inducing the genomic instability or oncogenic transformation often associated with traditional immortalization methods like the SV40 Large T antigen. These established cell lines are invaluable for high-throughput drug discovery, complex disease modeling, and longitudinal studies of cellular signaling pathways. Moreover, the use of the EF1a promoter makes these particles ideal for experiments involving cell differentiation, as the promoter remains active throughout various developmental stages. This functionality is particularly advantageous in regenerative medicine and tissue engineering, where maintaining a stable cell population with a consistent genotype is essential for evaluating long-term biological outcomes and therapeutic efficacy.